Compounds > bromodeoxyuridine
Page last updated: 2024-08-17

bromodeoxyuridine and quetiapine fumarate

bromodeoxyuridine has been researched along with quetiapine fumarate in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deng, Y; Devon, RM; Dyck, LE; He, J; Jiang, W; Li, X; Li, XM; Wei, Z; Xiao, L; Xu, H; Zhang, Y1
Bi, X; Fang, S; He, J; Kong, J; Li, XM; Yan, B; Yang, Y1
Bi, X; Fang, S; He, J; Kong, J; Li, XM; Tan, Q; Yan, B; Zhang, D; Zhang, Y; Zhang, Z1
Chang, T; Chen, YC; Peng, ZW; Tan, QR; Wang, HN; Wang, Y; Wu, WJ; Zhang, RG1
Chikama, K; Kajitani, K; Nakabeppu, Y; Tsukamoto, T; Uchimura, N; Yamada, H1

Other Studies

5 other study(ies) available for bromodeoxyuridine and quetiapine fumarate

ArticleYear
Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes.
    Molecular psychiatry, 2008, Volume: 13, Issue:7

    Topics: Animals; Antipsychotic Agents; Behavior, Animal; Bromodeoxyuridine; Cell Aggregation; Cells, Cultured; Cerebral Cortex; Dibenzothiazepines; Humans; Mice; Mice, Inbred C57BL; Myelin Sheath; Oligodendroglia; Postmortem Changes; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Schizophrenia; Tetrazolium Salts

2008
Quetiapine regulates neurogenesis in ischemic mice by inhibiting NF-kappaB p65/p50 expression.
    Neurological research, 2009, Volume: 31, Issue:2

    Topics: Animals; Antipsychotic Agents; Brain Ischemia; Bromodeoxyuridine; Cell Count; Cell Proliferation; Dibenzothiazepines; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Hippocampus; Male; Mice; Mice, Inbred ICR; Neurogenesis; NF-kappa B p50 Subunit; Quetiapine Fumarate; Transcription Factor RelA

2009
Quetiapine prevents oligodendrocyte and myelin loss and promotes maturation of oligodendrocyte progenitors in the hippocampus of global cerebral ischemia mice.
    Journal of neurochemistry, 2012, Volume: 123, Issue:1

    Topics: Analysis of Variance; Animals; Antigens; Antipsychotic Agents; Brain Ischemia; Bromodeoxyuridine; Carotid Artery Diseases; Cell Differentiation; Dibenzothiazepines; Disease Models, Animal; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Hippocampus; Male; Mice; Myelin Basic Protein; Myelin Sheath; Oligodendroglia; Proteoglycans; Quetiapine Fumarate; Time Factors

2012
Quetiapine add-on therapy improves the depressive behaviors and hippocampal neurogenesis in fluoxetine treatment resistant depressive rats.
    Behavioural brain research, 2013, Sep-15, Volume: 253

    Topics: Animals; Antidepressive Agents, Second-Generation; Antimetabolites; Antipsychotic Agents; Bromodeoxyuridine; Cell Count; Cell Proliferation; Depressive Disorder; Dibenzothiazepines; Drug Resistance; Drug Therapy, Combination; Eating; Environment; Fluoxetine; Hippocampus; Immunohistochemistry; Male; Neurogenesis; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Stress, Psychological; Sucrose; Swimming; Tissue Fixation

2013
Chronic atypical antipsychotics, but not haloperidol, increase neurogenesis in the hippocampus of adult mouse.
    Brain research, 2017, Dec-01, Volume: 1676

    Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bromodeoxyuridine; Cell Count; Clozapine; Haloperidol; Hippocampus; Immunohistochemistry; Male; Mice, Inbred C57BL; Neurogenesis; Neurons; Olanzapine; Quetiapine Fumarate

2017